 |
市場調查報告書
商品編碼
1550678
寵物糖尿病照護設備市場：依動物類型、解決方案、最終用戶、地區Pet Diabetes Care Devices Market, By Animal Type, By Solutions (Treatment, and Glucose Monitoring Devices), By End User, By Geography |
||||||
預計2024年全球寵物糖尿病護理設備市場規模為24.2億美元，預計2031年將達到39.1億美元，2024年至2031年的複合年成長率為7.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 24.2億美元 |
| 實際資料 | 2019年至2023年 | 預測期 | 從2024年到2031年 |
| 預測 2024-2031 年複合年成長率： | 7.10% | 2031年價值預測 | 39.1億美元 |
近年來，全球寵物糖尿病護理設備市場經歷了顯著成長。寵物肥胖率的上升和寵物的人性化程度不斷提高，導致人們對寵物健康、預防保健和寵物疾病治療的認知不斷提高。寵物飼主積極監測血糖值，並透過注射胰島素和治療性飲食來控制寵物的糖尿病。人們已經開發出各種技術來實現寵物糖尿病管理的非侵入性監測和胰島素管理。連續血糖監測 (CGM) 系統、胰島素幫浦和採血筆的進步正在簡化寵物的糖尿病治療。寵物保險覆蓋範圍的擴大和寵物護理支出的增加也支撐了對寵物糖尿病護理設備的需求。然而，高昂的設備和處理成本是市場成長的主要挑戰。
（市場動態）：。
寵物肥胖率上升、開發中國家寵物擁有增加、寵物健康和疾病管理意識不斷提高、新產品推出以及技術進步等關鍵因素正在推動全球寵物糖尿病護理設備市場的成長。然而，與血糖監測設備、治療和獸醫護理相關的高成本是阻礙這些技術廣泛採用的主要因素。市場開拓公司致力於透過技術創新開發價格實惠的解決方案，以擴大新興市場地區的基本客群。對寵物護理新興企業的資金籌措的增加表明，不僅有進入開拓市場的機會，而且還有開發新解決方案的機會。
（本次調查的主要特點）
該報告對全球寵物糖尿病護理設備市場進行了詳細分析，提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球寵物糖尿病護理設備市場的主要企業。
本研究涵蓋的主要企業包括Abbot Laboratories, Inc、Virbac、Medtronic plc、Johnson &Johnson Services, Inc、Roche Diagnostics、Bio-Rad Laboratories, Inc、Novo Nordisk A/S、Zoetis Inc、Terumo Corporation、Boehringer，其中包括Ingelheim International GmbH、IDEXX Laboratories、Johnson &Johnson Services, Inc.、Terumo Corporation、Eli Lilly and Company、Vetoquinol SA 和 i-SENS, Inc.
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球寵物糖尿病護理設備市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場預測
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
第4章全球寵物糖尿病照護設備市場，依動物類型，2024-2031
- 狗
- 貓
第5章全球寵物糖尿病護理設備市場（按解決方案）2024-2031 年
- 治療
- 胰島素治療
- 血糖值監測裝置
第6章 全球寵物糖尿病照護設備市場，依最終使用者分類，2024-2031 年
- 獸醫診所
- 家庭護理設置
- 動物醫院
第7章2019-2031年全球寵物糖尿病照護設備市場（按地區）
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第8章 競爭格局
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol SA
- i-SENS, Inc.
第9章 分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第10章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The global pet diabetes care devices market is estimated to be valued at USD 2.42 Billion in 2024 and is expected to reach USD 3.91 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 2.42 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.10% | 2031 Value Projection: | US$ 3.91 Bn |
The global pet diabetes care devices market has been witnessing significant growth in the recent times. Rising pet obesity levels and increasing pet humanization have resulted in greater awareness about pet health, preventive care, and treatment of pet diseases. Pet owners are making active efforts towards monitoring blood glucose levels and managing diabetes in pets through insulin administration and therapeutic diet. Various technologies have been developed for diabetes management in pets which enables the non-invasive monitoring and administration of insulin doses. Advancements in continuous glucose monitoring (CGM) systems, insulin pumps, and lancing devices have simplified diabetes care for pets. Growing pet insurance coverage and rising pet care expenditure also supports the demand for specialized pet diabetes care devices. However, high cost of devices and therapy remains a key challenge for market growth.
(Market Dynamics):
Key factors, such as rising pet obesity, growing pet ownership in developing nations, increasing awareness about pet health and disease management, new product launches, and technological advancements, are fueling the growth of global pet diabetes care devices market. However, high cost associated with glucose monitoring devices, therapy and veterinary care is a major factor hampering the widespread adoption of these technologies. Market players are focusing on developing affordable solutions through innovations to expand their customer base in developing regions. Rising venture capital funding in pet care startups indicate strong opportunities for development of novel solutions as well as penetration in untapped markets.
(Key Features of the Study):
This report provides in-depth analysis of the global pet diabetes care devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pet diabetes care devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., i-SENS, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pet diabetes care devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet diabetes care devices market.
Detailed Segmentation-
- By Animal Type
- Dogs
- Cats
- By Solutions
- Treatment
- Insulin Therapy
- Insulin Delivery Devices
- Other Treatments
- Glucose Monitoring Devices
- By End User
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Key Players Insights
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
- i-SENS, Inc.
Table of Contents
1. Research objectives and assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Pet Diabetes Care Devices Market, By Animal Type
- Global Pet Diabetes Care Devices Market, By Solutions
- Global Pet Diabetes Care Devices Market, By End User
- Global Pet Diabetes Care Devices Market, By Region
3. Market dynamics, regulations, and trends analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Pet Diabetes Care Devices Market, By Animal Type, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Pet Diabetes Care Devices Market, By Solutions, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Insulin Therapy
- Insulin Delivery Devices
- Other Treatments
- Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Pet Diabetes Care Devices Market, By End User, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Pet Diabetes Care Devices Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- U.S.
- Canada
- Latin America
- Introduction
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- South Africa
- North Africa
- Central Africa
8. COMPETITIVE LANDSCAPE
- Abbot Laboratories, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- i-SENS, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
